fiextGen Diagnostics New era in clinical analysis A group of OPERON medical systems GSTIN: 37FVDPK3027G1Z0 # 45-30-9 Sangam office building, Akkayyapalem, Visakhapatnam - 530016 M: +918978780621, +918978780622 mail id: nextgendiagnostic@gmail.com issued to: Name “SURYA RegitrationNo. + 310802/ VSDCIOI Sex/Age £05 Years Sample Registered On: 31-AUG-2028 17:36 Referred by: 01 Hash Pav. & Sample Received On: 31-AUG-2073 18:03 Requested Code Reported On 2 SFAUG-2023 19:88 Name: ReportedPrinted On: 31-06-2023 1952 Client Name = SELE Sample Type: Serum Branch Name : Nex Gen Dingostics IMMUNOASSAY [fest Description Value Observed Unit Biological Reference Interval Thyroid Function Test Tri-iodothyronine (T3) 79.3 ne/dt 80-210 “ - Pregnancy: ast Trimesters:81 - 190 2nd & 3rd Trimester: 100-260 Thyroxine (4) 64 afd 32.126 ‘Thyroid stimulating Hormone (TSH) 083 uf 07-64 re Pregnancy: Remarks: Please Correlate Clinically. Interpretation: Ast Trimester:0.24-2.99 2nd Trimester: 0.46 - 2.95 3rd Teimester:0.43 - 2.78 ‘reulating TSH measurement has been usd screening or euthyrodsm,srening and agnosis for hyperthyroidism & hypothyroid. Suppressed TH {0001 ulU/m) soggests a tanose of hyperthyoim and elevated concentration 97 uml suggest hypothyroid. TSH levels may be feted Wy 22 Ines and severamedetions including dopamine an lacocortcas- Decreased low undetectable) a Graves seas. Increased in TSHSetretig atutary denoma (secondary hypethyossm), RTH ain hypotialamic dear thyrotropin tertiary hyperthyroid), elevated hypothyroidism lon th eereased Ta) exept for play & hypothalamic disease. ‘Mido modest slevationsin patient wth aarmal73& a evlsndctes impaiced thyroid hormone reserves &incpent hypothyroid evn hypothyroidism, pressed TSH ve Mid to mares decrease with normal 3 & TA indicates suelnical hypethyoim, Degree of TSH supresion des nat fet the severity of hypertyrida,theefre, measurement of ree thyrid hormone eet required patie with End of Report Thefree T&T (FT2& FTA) messes concentrations offre hormones whic are not affected chaning concentraton of binding reteins therefore Note: Assy rests shoud be interpreted only inthe contest of ther borstory findings andthe total cna stats of the patent or test performed on specimens Fecaled or coected rom non Vi locations ts presumed that the specimen belongs othe patient named or dented slbeled onthe cotane/test request ‘eh eration has Ben cated aut a the point generation of the id specmen the ender,